Gram-negative bacteria are surrounded by an asymmetric outer membrane in which the inner leaflet is composed primarily of phospholipids and the outer leaflet contains mainly lipopolysaccharide (LPS) (Fig. 1a) . LPS forms a structural barrier that protects Gram-negative bacteria from environmental stressors, including antibiotics 1,2 . LPS is anchored to the outer membrane by lipid A, a glucosamine-based saccharolipid. Lipid A biosynthesis is required for Gram-negative species' viability and pathogenesis 3, 4 and is therefore a promising target against which to develop antimicrobial therapeutics 1 . Although all steps in the pathway (Fig. 1b) are conserved, the UDP-2,3-diacylglucosamine hydrolysis is carried out by either of two isozymes 5, 6 : by LpxH in 70% of Gram-negative bacteria and by LpxI in the 30% that include C. crescentus and several genera of human pathogens, among them Rickettsia, Brucella and Leptospira. We previously characterized LpxI from C. crescentus 7 (termed CcLpxI) as a peripheral-membrane metal-dependent hydrolase that accesses its normally bilayer-resident substrate and produces the same product as LpxH but by a different mechanism. LpxI catalyzes the attack of water on the β-phosphate of UDP-2,3-diacylglucosamine, as opposed to the attack on the α-phosphate that is catalyzed by LpxH 7 . To provide insight into this mechanism, we endeavored to determine the structure of this new class of phosphodiester hydrolase required for lipid A biosynthesis in a subset of Gram-negative bacteria. We hypothesized that these LpxI structures could offer a rare comparison of the substrate and product complexes of an enzyme that acts on saccharolipids and could perhaps reveal a novel and specific lipid-binding domain 8 .
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RESULTS

Flexibly linked binding and catalytic domains
The CcLpxI structure ( Fig. 2 and Table 1) shows that it incorporates a novel lipid-binding domain attached by a flexible linker to a C-terminal nucleotide phosphodiester hydrolase. In solution, CcLpxI chromatographs as a dimer (Supplementary Fig. 1a ) in which each monomer possesses two domains (Fig. 2) . The N-terminal lipid X-binding domain (LXD; residues 1-118) comprises a five-stranded parallel β-sheet surrounded by two α-helices on one side and three on the other. The LXD is bisected by a lipid-binding cleft formed by β-strands 1-5 on one side and by α-helices 3-5 on the other (Fig. 2) . A linking region (residues 118-144), containing an α-helix, connects the LXD to the C-terminal catalytic domain of CcLpxI (ICD). The N-terminal domain of CcLpxI lacks sequence homology to any other known protein.
The ICD (residues 144-280) comprises a five-stranded mixed β-sheet bracketed by one α-helix on one side and three on the other (Fig. 2) . This domain has structural homology, though no sequence homology, to a superfamily that includes cytosine deaminase 9 and various other proteins that do not share conservation of active sites or mechanisms. This motif presumably can be tuned to different enzymatic functions.
The ICD contains 11 polar residues that are absolutely conserved among the many LpxI homologs with previously unknown function (Fig. 3) , which we probed by mutagenesis for their role in catalysis and some of which we determined to be necessary for CcLpxI activity (Supplementary Table 1 ). Three of these residues, Gln220, Asp225 and Arg223, are present on a loop between ICD β3 and α3 (Fig. 2a) . No polar residues are absolutely conserved in the LXD of CcLpxI and its homologs, consistent with nonspecific hydrophobic interactions driving the association of the aliphatic chains with LXD.
CcLpxI co-purifies and co-crystallizes with its product, lipid X Intending to crystallize apoCcLpxI, we were surprised to discover that wild-type CcLpxI co-purified and co-crystallized with its product, lipid X, which is normally present at <0.2% of total Escherichia coli lipid 10 . We found that, unexpectedly, overexpression of the enzyme caused the accumulation of lipid X, to the level of ~25% of total chloroform-soluble E. coli lipids (L.E.M., unpublished data). This demonstrates that the overexpressed enzyme is active and suggests that the synthetic pathway to LPS may be regulated to match the throughput of CcLpxI and may be restricted, in this case, by the throughput of the next enzyme in the pathway, LpxB, which uses one molar equivalent of the LpxI substrate and one equivalent of the LpxI product (Fig. 1b) .
The experimental density maps (2.9 Å) revealed lipid X bound to LXD but distantly from all residues in the catalytic domain (Fig. 4a-c) . The B factors of the acyl moieties of lipid X are similar to those of the surrounding side chains in the LXD, which shows that the product is bound with high occupancy. The lipid X-binding site is remarkable in that the aliphatic chains are completely buried and surrounded almost entirely by hydrophobic interactions. The glucosamine-1-phosphate moiety is positioned far out into the solvent, and the density is consistent with two orientations of lipid X, related by a 180° rotation about the long axis (Fig. 4a-c and Supplementary Fig. 2 ). The hydrophobic pocket enveloping the acyl chains is precisely complementary to the geometry of a hexose acylated in the equatorial configuration at the 2 and 3 positions. This may explain the selectivity (as observed for the product here) against binding glycerolphospholipids. The latter can adopt the same geometry but with an entropic cost not necessary in the fixed nonreducing hexose ring locked by the 1-phosphate. The binding pocket (Fig. 4c) was calculated to have an internal surface area of ~650 Å 2 and a volume of ~800 Å 3 (by MetaPocket 2.0 (ref. 11) and CaspT 12 ).
To confirm the identity of the molecule that co-purified with CcLpxI, the protein was subjected to a single-phase acidic BlighDyer 13 extraction, and the organic phase was subjected to liquid chromatography run in-line with an electrospray time-of-flight mass spectrometer operating in negative-ion mode, as previously described 14 . A singly charged species of exact mass [M-H] −1 710.42 AMU, consistent with pure lipid X, was isolated as a discrete peak eluting from the normal-phase column at 22.1 min ( Supplementary  Fig. 3a) . Secondary fragmentation yielded components only consistent with lipid X (Supplementary Fig. 3b,c) . The total spectrum of the chromatogram did not contain peaks consistent with any other copurifying lipids, including the common E. coli glycerolphospholipids (Supplementary Fig. 3a) .
To determine the stoichiometry of lipid X:CcLpxI, we measured the fraction of lipid X bound to CcLpxI by comparing [ 32 P]PO 4 -lipid X on CcLpxI purified from E. coli grown in [ 32 P]PO 4 , versus total [ 32 P]PO 4 -lipid X, in a manner analogous to that previously described 15 . The total mass of phospholipids was determined from a matched nonradioactive growth. The amount of total lipid X was evaluated by knowing the fraction of total extractable lipids that was lipid X, on the basis of thin-layer chromatograms. The amount of CcLpxI-bound radiolabeled lipid X was compared with the amount of CcLpxI as determined by 
A single point mutant of CcLpxI co-purifies with its substrate
Because CcLpxI co-purified with its product, lipid X, we sought to produce a catalytically deficient point mutant wherein the substrate UDP-2,3-diacylglucosamine was bound to the enzyme but not hydrolyzed. We therefore made separate mutations to alanine at each of a selected set of seven polar residues in the ICD that are absolutely conserved among CcLpxI orthologs (Fig. 3) , and we expressed these constructs in E. coli (Supplementary Table 1 and Supplementary Figs. 4 and 5). The chloroform-soluble fractions from acidic Bligh-Dyer extractions of crude lysates from these cells were analyzed by electrospray time-of-flight mass spectrometry (Supplementary Fig. 6 ). In E. coli in which mutant CcLpxI-D225A was expressed, we observed the accumulation of doubly charged and singly charged species consistent with the substrate UDP-2,3-diacylglucosamine ( Supplementary  Fig. 6i,j) . The MS/MS fragmentation pattern for the singly charged species isolated from purified CcLxpI-D225A established that it was UDP-2,3-diacylglucosamine ( Supplementary Fig. 3d-f) .
No species of UDP-2,3-diacylglucosamine were observed in E. coli expressing empty vector ( Supplementary Fig. 6b,c) , wild-type CcLpxI ( Supplementary Fig. 6e,f) or the other CcLpxI point mutants.
CcLpxI-D225A was purified to near homogeneity, as with CcLpxI (Online Methods). We confirmed that CcLpxI-D225A co-purified with UDP-2,3-diacylglucosamine by directly spotting protein from size-exclusion chromatographic fractions on a thin-layer chromatography plate and visualizing the lipid by charring with H 2 SO 4 ( Supplementary Fig. 1 ). We performed LC-MS/MS on the single-phase acidic BlighDyer-extracted purified CcLpxI-D225A, as described above for CcLpxI. A singly charged species having a mass consistent with UDP-2,3-diacylglucosamine (exact mass:charge ratio of [M-2H] −2 of 507.73 or [M-H] −1 of 1,016.47) was isolated in a discrete peak eluting from the normalphase column at 21.2 min ( Supplementary  Fig. 3d ). Secondary fragmentation yielded ions characteristic of UDP-2,3-diacylglucosamine ( Supplementary Fig. 3e,f) . The total spectrum of the LC run did not contain peaks consistent with other co-purifying lipids, including common E. coli glycerolphospholipids (Supplementary Fig. 3d ). Therefore, Figure 3 Absolutely conserved polar residues mapped to the structure of CcLpxI-D225A. (a) CcLpxI-D225A, in gray cartoon rendering of the putative CcLpxI-D225A dimer, shown in stereo, with a semitransparent gray surface shown on one monomer of the dimer. Its substrate, UDP-2, 3-diacylglucosamine, is shown as yellow sticks; absolutely conserved polar residues thought to be involved in substrate binding and/or catalysis are shown as teal sticks; and absolutely conserved polar residues residing at the hypothetical dimerization interface are shown as magenta sticks. The Cβ of Ala225 is shown as a purple stick and is labeled D225A to indicate its mutation from Asp225 in this structure. (b) Absolutely conserved polar residues within the wild-type CcLpxI sequence (boxed, colored residues). Residues thought to be involved in substrate binding and/or catalysis are colored in teal, residues hypothesized to be involved in dimerization are shown in magenta, and Asp225 is shown in purple. An asterisk under a residue indicates that alanine-scanning mutagenesis was performed on that residue (Supplementary Table 1 ).
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Asp225 is a key catalytic residue, and the D225A mutant still binds its substrate without hydrolyzing it.
The substrate-binding pocket comprises two domains Purified CcLpxI-D225A was crystallized in different conditions and in a different space group than CcLpxI ( Table 1) . The structure was therefore determined independently by single-wavelength anomalous diffraction to 3.0-Å resolution from selenomethionine (SeMet)-derivatized crystals. A low-resolution structural model was built into this density and used to phase a 2.55-Å native data set. Strong density indicated that UDP-2,3-diacylglucosamine substrate spanned both the LXD and the ICD, with LXD enveloping the acyl chains of the lipid X moiety and ICD engaging in well-defined hydrophilic interactions with the headgroup (Fig. 4d-f) . The glucosamine moiety of the substrate is in a strained chair conformation (Fig. 4e) . The LXD and ICD domains are hinged closed around the substrate (Fig. 4f) . As a result of domain closure, the binding pocket has a greatly increased internal surface area of ~1,500 Å 2 and a volume of ~2,500 Å 3 relative to 650 Å 2 and 800 Å 3 , respectively, in the product-liganded structure. The B factors of the UDP-2,3-diacylglucosamine atoms are similar to those of the surrounding side chains (Fig. 5a) .
Evidence for the CcLpxI dimerization interface
The molecular weight of CcLpxI is 29.4 kDa. The apparent solution molecular masses of purified CcLpxI-D225A and CcLpxI were estimated by sedimentation equilibrium, as described in Online Methods. For CcLpxI, two separate measurements yielded apparent molecular masses of 58.9 and 56.9 kDa, indicating that the protein is a dimer in solution. For CcLpxI-D225A, measurements yielded 63.7 and 57.0 kDa. Elution volumes on calibrated size-exclusion columns are also consistent with both CcLpxI and LpxI-D225A being dimers. Both CcLpxI (space group I4 1 22) and CcLpxI-D225A (P6 1 22) share a common interface across a crystallographic two-fold axis (Fig. 5b,c) . The interface in CcLpxI has a buried surface area of 2 × 1,150 Å 2 versus 2 × 1,225 Å 2 in CcLpxI-D225A. Comparison of interactions between monomers by using the program PISA 16 predicted this to be a stable interface. Glu185 and Arg193, the only conserved polar residues outside the substrate-binding cavity, lie in the interface. They form an intramolecular buried salt bridge and coordinate an intermolecular π-stacking of both Arg193 amidinium groups in the interface (Fig. 5a, inset) . When Glu185 was mutated to alanine (denoted CcLpxI-E185A) and expressed in E. coli, the UDP-2,3-diacylglucosamine hydrolase activity of the crude lysate was reduced to <0.25% of the activity of lysate in which wild-type CcLpxI was expressed to similar levels. (Supplementary  Table 1 and Supplementary Fig. 5) , and it was proteolyzed in vivo ( Supplementary Fig. 4 ), which suggests a role for this interaction in stabilizing the dimer interface. The R193A mutant of CcLpxI had a wild-type level of UDP-2,3-diacylglucosamine activity (Supplementary Table 1 and Supplementary Fig. 5) , and thus its role in putative interface stabilization is unclear.
The domains swing open on forming the CcLpxI-product complex Whereas LXD and ICD are closed in the substrate-bound D225A complex, they are opened by ~70° and rotated by ~80° in the product-bound complex (Fig. 5b,c) 
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for Cα of the ICD on superposition). The linking loop in the CcLpxI-D225A-substrate complex becomes a helix in the CcLpxI-product complex ( Fig. 2 and Fig. 5b,c) .
Although the observed conformational differences between CcLpxI-D225A and CcLpxI may represent states along a true catalytic pathway, we cannot exclude the possibility that these conformations are artifacts of crystal packing. To probe the solution conformations, we determined their sedimentation velocities. The sedimentation coefficient of CcLpxI-D225A was 3.85 ± 0.09 S (n = 5), whereas that of CcLpxI was 3.56 ± 0.11 S (n = 5), consistent with the more elongated shape of the product complex. Additional evidence for the substrate complex having a smaller hydrodynamic radius than the product complex is the increase in elution volume on a calibrated size-exclusion column (Supplementary Fig. 1a) .
DISCUSSION
An interfacial lipid hydrolase
LpxI is a UDP-2,3-diacylglucosamine hydrolase present in many Gram-negative bacteria. In these species, it has an essential role in the biosynthesis of lipid A (Fig. 1) , the hydrophobic anchor of LPS in several pathogenic genera including Rickettsia, Brucella and Leptospira 1,2 . Here we report the first structure, to our knowledge, of any UDP-2,3-diacylglucosamine hydrolase, which represents a new family of phosphodiester hydrolases. As it is required for growth and viability of these and other lethal pathogens, and as it has no apparent mammalian homolog, LpxI is a potentially attractive enzyme target for antimicrobials. LpxI is a divalent metal ion-dependent hydrolase that catalyzes the attack of water on the β-phosphate of UDP-2,3-diacylglucosamine, an integral membrane lipid substrate and product 7 (Fig. 1b) .
Crystals of CcLpxI were obtained in the presence of lipid X, which serendipitously co-purified stoichiometrically with CcLpxI. The structure, determined at 2.9-Å resolution, consists of two domains: an N-terminal lipid X binding domain (LXD) and a C-terminal LpxI catalytic domain (ICD) (Fig. 2 and Fig. 5 ). This is a new arrangement of domains; each domain has a fold similar to distantly related protein domains having unrelated functions, but the combination of these in one protein is newly identified. The hydrophobic binding pocket is strikingly similar to that observed in Sec14 (ref. 17 ) and in various PH domain (lipid-binding domain)-fused proteins 8, 18 . Relatively few residues are positioned such that they might interact with the headgroup of lipid X. For this reason, the mode of lipid X binding to CcLpxI is reminiscent of how exogenous lipids are bound by many members of the CD1 family of receptors 19, 20 or of how lipid A binds to human Toll-like receptor 4 (refs. 21,22) , albeit without participation of the 1-phosphate. In this regard, LpxI differs from the structure of product-bound LpxA, the first enzyme of the lipid A biosynthetic pathway, which has high specificity for its ligand's hydrophilic headgroup 23, 24 . To date, fewer than 20 families of lipid-binding domains have been described 25, 26 ; the LXD of CcLpxI represents a new specific lipid-binding domain.
Thermodynamic coupling at the dimer interface
The presence of two absolutely conserved LpxI residues at the dimer interface (Fig. 5) npg a r t i c l e s catalytic subunits. The substrate-bound form has 150 Å 2 larger buried surface area than the product-bound dimer and has several more hydrogen bonds and salt bridges. This suggests that the cost of introducing strain (Fig. 4e,f) into the glucosamine moiety upon enzyme closure can be balanced in part by the dimer interface to favor substrate binding and product release when substrate is available, in this conformationally coupled mechanism.
Interfacial catalytic mechanisms
We propose a catalytic model in which the LXD and ICD each form halves of an interdomain active site (Fig. 6) . The mode of LpxI catalysis requires Asp225, Mg +2 and catalytic water(s) not yet seen in the D225A structure. The fact that we purified substrate (in the mutant) and the lipid-product complexes from whole cells suggests that the default state in vivo is lipid-product bound (without UMP bound) and that available substrate must contribute to product release (Fig. 6) . The driving force for the LXD and ICD domain rearrangement could be hydrolysis and release of the soluble UMP product. Another possible driving force is the strained conformation of the substrate's chair-form glucosamine ring (Fig. 4e,f) . Substrate binding and product release must be effected either by adjacent enzymes in a hypothetical multimeric lipid A synthome, such as LpxB (Fig. 1b) , or by the lipid bilayer.
Glutamates and aspartates have diverse roles in phosphodiester cleavage. We have shown that Asp225 is required for LpxI-catalyzed hydrolysis. However, even within a family of hydrolases, such as the nudix proteins 27-31 , these 'catalytic bases' can have different functions, including the direct deprotonation of the catalytic water, the orientation of a catalytically essential water shell, the binding of divalent metal ligands, which in turn coordinate catalytic water and/or the substrate's phosphodiester moiety. Although detailed mechanistic hypotheses cannot be developed on the basis of the present data, it is clear that CcLpxI operates differently than do most other nucleotide pyrophosphatases. Although such phosphatases perform catalysis by a variety of mechanisms and with sundry ensembles of active site residues, most appear to do so without major macromolecular rearrangements. CcLpxI differs in evoking large conformational-dynamic trajectories. Asp225's role in LpxI could be probed further by mutating Asp225 to cysteine, then reacting the resulting D225C mutant with iodoacetate to restore a carboxyl. Asp225's role may be directly catalytic or may affect substrate binding.
To our knowledge, CcLpxI is the only example of a nucleotide pyrophosphatase that remains bound to its non-nucleotide product, following catalysis. This unusual property may reflect the cost of solvating lipid X binding site and lipid X on removal of the protein from the bilayer environment (Fig. 6) . We therefore speculate that with LpxI, substrate binding drives the release of lipid X. In this regard, LpxI may more closely resemble two-domain glycosyltransferases, wherein acceptor nucleotide-sugar hydrolysis appears to drive domain movements and/or product release 32 .
An interesting possibility is that LpxI, under chromosomal expression control, may normally form a complex with the next enzyme in the pathway, LpxB (Fig. 1b) , in its cognate species. The lipid A disaccharide synthase LpxB, like LpxI, acts on lipid substrates located in the inner leaflet of the inner membrane of Gram-negative bacteria. Given the low steady-state levels of UDP-2,3-diacylglucosamine and lipid X in bacteria 10, 33, 34 , the hypothesis that LpxI (or its analog LpxH in other species) transfers one molecule of lipid X for fusion with one of UDP-2,3-diacylglucosamine on LpxB as part of a bacterial lipid A-synthesis enzyme complex seems plausible in the Raetz pathway for lipid A biosynthesis.
The present study provides a basis for future biochemical and biophysical characterization of this unique family of metal-dependent UDP-diacylglucosamine hydrolases and constitutes a starting point for structure-based inhibitor identification and antimicrobial development, perhaps focusing on uridine analogs. The structure opens the horizon for understanding interfacial catalysis of lipids at the membrane surface.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Structures have been deposited in the PDB, with accession codes 4GGM (LpxI) and 4GGI (LpxI-D225A mutant).
ONLINE METhODS
Strain construction, protein purification and activity assay. Briefly, CcLpxI and CcLpI-D225A were expressed from a high-copy, isopropyl β-d-1-thiogalactopyranoside-inducible plasmid conferring N-terminal His 10 tags cleavable by Tobacco etch virus protease. Expression was accomplished by using a T7 expression system in E. coli strain C41(DE3) 35 . Cells were lysed by mechanical disruption, and tagged CcLpxI or CcLpxI-D225A was purified by immobilized metal-exchange chromatography followed by anion-exchange chromatography, cleavage of the polyhistidine tag by Tobacco etch virus protease, reverse immobilized metal-exchange chromatography and, finally, sizeexclusion chromatography.
All CcLpxI assay conditions described in this work were identical to those previously described 7 . Briefly, each 25-µl reaction contained the following components: 100 µM UDP-2,3-diacylglucosamine, 0.5 mg/ml bovine serum albumin (BSA), 0.05% w/v Triton X-100, 20 mM HEPES, pH 8.0, 2 mM MgCl 2 and 1,000 d.p.m./µl [β-32 P]PO 4 -labeled UDP-2,3-diacylglucosamine. All assays were conducted at 30 °C and quenched by spotting portions of the reaction onto silica TLC plates, which were developed, visualized and quantified as previously described 7 .
Crystallization and data collection for CcLpxI and CcLpxI-D225A. Native and SeMet-substituted CcLpxI were crystallized and cryoprotected in identical conditions. Mixed drops of CcLpxI (20-30 mg/ml) and well solution were set up in a ratio of 7:3 v/v in sitting-drop vapor-diffusion chambers. The well solution consisted of 100 mM MES, pH 5.7, 3-7% w/v PEG 6000 and 2.5% v/v glycerol. Crystals, with typical dimensions of ~200 × 200 × 400 µm, formed at 4 °C between 1 and 3 d and continued to grow for 5-7 d. The crystals were rectangular pyramids and bi-pyramids. This crystallization condition was robust and was reproducible with reagents from different suppliers.
Crystals of CcLpxI were fragile and disintegrated when touched with nylon loops or other crystal-harvesting implements. Therefore, CcLpxI was cryoprotected in situ by gradually exchanging the sitting-drop buffer with glycerolcontaining cryoprotection solutions until a final concentration of 40% v/v glycerol was achieved. During cryoprotection, the dimensions of the crystals decreased slightly, as expected for a vitrification process. In concentrations of glycerol greater than 30% v/v, the CcLpxI crystals could be manipulated without damaging them. Although other cryoprotectants were tested, including PEG400, xylitol, MPD and ethylene glycol, screening revealed that optimal X-ray diffraction could be obtained by cryoprotection with buffers containing 35-40% v/v glycerol and supplemented with MgCl 2 to 2 mM.
SeMet-substituted CcLpxI-D225A crystals were grown at 20 °C by hangingdrop vapor diffusion. The well solution consisted of 100 mM Tris, pH 7.5-9.0, 180-200 mM NaCl, 1.3-1.6 M (NH 4 ) 2 SO 4 and 6% v/v glycerol. Large crystals, in the form of hexagonal prisms and spears, often exceeded 500 µm in length. Crystals appeared in 1-2 d and continued to grow for another 3-5 d. This crystallization condition was robust and was reproducible.
Native CcLpxI-D225A were grown at 20 °C by hanging-drop vapor diffusion. The well solution consisted of 1.6-2.2 M NaCl and 8-14% v/v PEG6000. Large crystals, in the form of hexagonal prisms and spears, often exceeded 500 µm in length. Crystals appeared in 1-2 d and continued to grow for another 3-5 d. This crystallization condition was robust and was reproducible with reagents from different suppliers.
In contrast to CcLpxI, CcLpxI-D225A crystals were not very fragile and could be easily harvested by using nylon loops. SeMet CcLpxI-D225A crystals were cryoprotected by using well solution substituted with glycerol to ~20% w/v, whereas native CcLpxI-D225A crystals were cryoprotected in their well solution supplemented with PEG400 in steps of 5% w/v until a concentration of 25% w/v PEG400 was obtained. Cryoprotection with glycerol and ethylene glycol yielded poorer diffraction than did PEG400.
Diffraction data were collected at the Lawrence Berkeley National Laboratory Advanced Light Source, Beamline 8.3.1, under a −170 °C nitrogen cryostream. As no homologs existed with which to phase CcLpxI, SAD data sets were collected on SeMet-derivatized crystals at the selenium absorption peak. The highest-resolution SeMet crystals diffracted to 2.9 Å. Phases were determined by SAD. For CcLpxI-D225A, SAD and MAD data sets were collected on SeMetderivatized crystals at the selenium absorption peak, near and far edges. The highest-resolution SeMet data set diffracted to 3.0 Å. Phases were determined by MAD. Native CcLxpI-D225A data sets were collected to 2.55 Å, and the unrefined structure was used to determine the phases for the native data set. Data processing was performed by using either HKL2000 (ref. 36) or ELVES 37 . Phasing by molecular replacement was performed using Phenix 38 . Building was done using Coot 39 , and refinement was accomplished by using Coot, Phenix and CCP4 (ref. 40) . The MolProbity [41] [42] [43] [44] server was employed for structural validation and improvement.
Lipid extraction and mass spectrometry. Co-purified lipids were extracted from 0.2-mg samples of protein (or crude E. coli cell lysate), purified by the method above, with a 5.8-ml acidic two-phase Bligh-Dyer system 13 . The extraction was performed as previously described 15 . When indicated, portions of the lipid extracts were spotted on silica thin-layer chromatography plates, separated and imaged as previously described 15 .
LC-MS analysis of total, single-phase Bligh-Dyer-extracted protein or E. coli crude-lysate samples, using a normal-phase column run with subsequent monitoring by ESI-MS/MS in the negative mode, was performed as previously described 45 . A 20-µl sample of each 7.6-ml single-phase acidic Bligh-Dyer extraction (0.25% of the total single-phase volume) was loaded onto an ~600-µl normalphase column (2.5% of bed volume). ESI-MS was performed by a QSTAR XL time-of-flight mass spectrometer coupled to an LC system. Data were analyzed with the aide of the Analyst QS software package.
Analytical ultracentrifugation. Sedimentation equilibrium experiments were used to estimate the molecular weights of purified CcLpxI and CcLpxI-D225A. Samples were prepared by diluting concentrated protein stocks into their storage buffer (20 mM HEPES, pH 8.0, 200 mM NaCl). For each construct, concentrations of 1, 2 and 3 mg/ml were each centrifuged at 8,060g, 18,150g and 201,600g, in a Beckman An-60Ti rotor in a Beckman Optima XL-A analytical ultracentrifuge. Centrifugation was performed at 20 °C. Samples were paired with reference cells containing buffer identical to that with which they were diluted. Absorbance was monitored at 240 nm. The program SEDNTERP 46 was used to calculate the buffer density (ρ = 1.0088), and the amino acid sequence of CcLpxI was used to calculate its partial specific volume (υ bar = 0.7371). Best-fit buoyant molecular weight (MW b ) was estimated by using the XL-A XLI-1 software suite, from which molecular weight was calculated by using the equation MW = MW b /(1 -υ bar ρ) (refs. 46,47) . Sedimentation-velocity experiments were used to determine the sedimentation coefficients of CcLpxI and CcLpxI-D225A. The proteins were diluted, as above, to 0.7, 1.4, 2.1, 2.6 and 3.1 mg/ml. These samples, paired with reference cells containing the protein buffer, were centrifuged at 2,900g in a Beckman An-60Ti rotor in a Beckman Optima XL-A analytical ultracentrifuge. For CcLpxI, absorbance was monitored at 245 nm, whereas CcLpxI-D225A was monitored at both 245 and 260 nm. Data were processed by using ProteoLab XL-A software, and weightaverage sedimentation coefficients (S) were determined by second-moment integration of the sedimentation absorbance profiles between the meniscus and solution plateaus 48 .
